New Stock Issuance - New stock for Beikang Testing (920160) issued at a price of 6.70 on November 3, 2025[1] - New stock for Danna Biology (920009) issued at a price of 17.10 on November 3, 2025[1] Market Alerts - ST Zhongdi (000609) announced significant abnormal fluctuations on October 30, 2025[1] - Jiangbolong (301308) reported severe abnormal fluctuations on October 30, 2025[1] - Xiangnan Chip (300475) disclosed abnormal fluctuations on October 24, 2025[1] - Shangtai Technology (001301) announced abnormal fluctuations on November 3, 2025[1] - Hainan Development (002163) reported abnormal fluctuations on November 3, 2025[1] - Zhongrui Co., Ltd. (002374) disclosed abnormal fluctuations on November 3, 2025[1] - Fujian Jinsen (002679) announced abnormal fluctuations on November 3, 2025[1] - Yongxing Materials (002756) reported abnormal fluctuations on November 3, 2025[1] - Xinhongze (002836) disclosed abnormal fluctuations on November 3, 2025[1] - Guocheng Mining (000688) announced abnormal fluctuations on November 3, 2025[1]

Core Viewpoint - *ST Aowei (SZ002231) experienced a trading halt with a price of 3.39 yuan, reflecting a 4.95% increase, and a total market capitalization of 1.176 billion yuan, driven by governance improvements, business growth, and institutional buying [1] Group 1: Governance Improvements - The company has actively improved internal management by revising and enhancing 22 governance systems, introducing a market value management system, and appointing qualified independent directors [1] - These measures are expected to positively impact the company in the medium to long term, boosting market confidence and stimulating stock price increases [1] Group 2: Business Growth - Certain business segments are showing growth, with military information technology product revenue increasing by 34.10% year-on-year and network optimization equipment sales soaring by 249.58% [1] - As a high-tech enterprise engaged in military electronic information and civil-military integration, this business growth supports the rise in stock price [1] Group 3: Institutional Buying - On October 29, the company was included in the "Dragon and Tiger List," with net institutional buying reported [1] - Data from Dongfang Caifu indicates that the trading volume on that day was 58.2867 million yuan, with total purchases of 43.1194 million yuan and total sales of 32.3292 million yuan, indicating a net inflow of institutional funds that contributed to the stock price increase [1] Group 4: Financial Performance - The company's Q3 2025 report showed a net profit attributable to shareholders of -188 million yuan, representing a year-on-year decline of 988%, indicating ongoing losses and significant risks of delisting [1]

Group 1 - The company *ST Aowei reported a significant decline in revenue and an increase in net loss for the first three quarters of 2025, with total revenue of 34.0025 million yuan, down 87.01% year-on-year, and a net loss of 188 million yuan compared to a loss of 17.2461 million yuan in the same period last year [1] - The company is facing investor lawsuits due to false statements regarding its financial performance, with a legal team from Shanghai Huzhi Law Firm currently representing the case [1] - The company had previously issued a warning regarding inaccurate disclosures in its earnings forecasts, which has led to a decline in stock price and subsequent investor claims [2] Group 2 - On January 24, 2025, the company initially forecasted its 2024 revenue to be between 450 million yuan and 520 million yuan, with a net loss of 32 million to 45 million yuan, but later revised these figures down to an expected revenue of 280 million to 299 million yuan and a net loss of 50 million to 75 million yuan [2] - The regulatory body has pointed out the inaccuracies in the company's disclosures, which could significantly impact stock prices and investor decisions [2] - Investors who purchased shares between April 26, 2024, and April 21, 2025, and sold or held them after April 22, 2025, at a loss are eligible to participate in the ongoing claims [2]

Group 1: New Stock Issuances - Multiple new stock issuances are scheduled for October 31, 2025, including Jiangbolong (301308) and Shikong Technology (605178) [1] - A total of 30 companies have announcements related to stock issuance or trading on this date [1] Group 2: Trading Alerts - Jiangbolong (301308) reported severe abnormal fluctuations in trading [1] - Other companies such as ST Wanfang (000638) and Yashichuangneng (603378) also have trading alerts on the same date [1] Group 3: Recent Announcements - Recent announcements include companies like Tianpu Co. (605255) and Kangsheng Co. (002418) with updates on October 31, 2025 [1] - The announcements cover various sectors, indicating a broad market activity [1]

Group 1 - The company *ST Aowei (SZ 002231) announced on October 31 that its 38th meeting of the sixth board of directors was held on October 29, 2025, to review the proposal for revising the management system for shares held by directors and senior management [1] - For the first half of 2025, the company's revenue composition was as follows: 66.97% from the metal products industry, 28.12% from the communication equipment manufacturing industry, and 4.91% from other businesses [1]

Core Viewpoint - *ST Aowei reported a significant decline in revenue and a substantial net loss for the third quarter of 2023, indicating ongoing financial challenges for the company [1]. Financial Performance - The company’s revenue for the first three quarters of 2025 was approximately 34 million yuan, representing a year-on-year decrease of 87.01% [1]. - The net profit attributable to shareholders was a loss of about 188 million yuan [1]. - The basic earnings per share showed a loss of 0.541 yuan [1].

本公司监事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 一、监事会会议召开情况 奥维通信股份有限公司（以下简称"公司"）第六届监事会第二十五次会 议（以下简称"本次会议"）于 2025 年 10 月 29 日在公司五楼会议室以现场投 票的方式召开。本次会议的通知已于 2025 年 10 月 24 日以电子邮件、专人传递 等方式发出。应出席本次会议的监事为 3 名，实际出席监事 3 名，符合《公司 法》及《公司章程》的规定。本次会议由监事会主席裴非先生主持，经与会监 事充分讨论和审议，会议形成如下决议： 二、监事会会议审议情况 1、会议以 3 票同意、0 票反对、0 票弃权的表决结果审议通过了《关于公 司 2025 年第三季度报告的议案》； 证券代码：002231 证券简称：*ST 奥维 公告编号：2025-076 奥维通信股份有限公司 第六届监事会第二十五次会议决议公告 经审核，监事会认为：董事会编制和审核奥维通信股份有限公司 2025 年第 三季度报告的程序符合法律、行政法规和中国证监会的规定，报告内容真实、 准确、完整地反映了上市公司的实际情况，不存在任何虚假记载 ...

证券代码：002231 证券简称：*ST 奥维 公告编号：2025-075 奥维通信股份有限公司 奥维通信股份有限公司（以下简称"公司"）第六届董事会第三十八次会 议（以下简称"本次会议"）于 2025 年 10 月 29 日在公司五楼会议室以现场结 合通讯的方式召开。本次会议的通知已于 2025 年 10 月 24 日以电子邮件、专人 传递等方式发出。应出席本次会议的董事为 7 名，实际出席董事 7 名。本次会 议由董事长杜方先生主持，符合《公司法》及《公司章程》的规定。经与会董 事充分的讨论和审议，会议形成如下决议： 二、董事会会议审议情况 1、会议以 7 票同意、0 票反对、0 票弃权的表决结果审议通过了《关于公 司 2025 年第三季度报告的议案》； 根据中国证监会及深圳证券交易所的相关法律法规要求，公司编制了《2025 年第三季度报告》。具体内容详见公司披露的《2025 年第三季度报告》（公告 编号：2025-077）。 第六届董事会第三十八次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 2、会议以 7 票同意 ...

奥维通信股份有限公司 信息披露事务管理制度 第一章 总 则 第一条 为了规范奥维通信股份有限公司（以下简称"公司"）的信息披露行为， 加强信息披露事务管理，促进公司依法规范运作，保护投资者特别是社会公众投资者的 权益，根据《中华人民共和国公司法》《中华人民共和国证券法》（以下简称"《证券 法》"）《上市公司信息披露管理办法》《深圳证券交易所股票上市规则》（以下简称 "《股票上市规则》"）等相关法律法规、规范性文件和《奥维通信股份有限公司章程》 （以下简称"《公司章程》"）对信息披露事务的有关规定，制定本制度。 第九条 公司信息披露文件主要包括招股说明书、募集说明书、上市公告书、收购报告 书、定期报告和临时报告等。 第二条 本制度对公司股东、全体董事、高级管理人员和公司各部门（含子公司）具 有约束力。 第三条 本制度所称"信息"是指所有对公司证券及其衍生品交易价格可能产生重 大影响而投资者尚未获知的重大信息，以及根据相关法律法规、制度、《股票上市规 则》等制度要求公司强制性披露的信息。 第四条 本制度所称"披露"是指在规定的时间，通过法定的媒体及方式向社会公众 公布前述信息以及按制度报送证券监管部门的行为。 第 ...

奥维通信股份有限公司 市值管理制度 第一章 总则 第一条 为加强奥维通信股份有限公司（以下简称"公司"）市值管理工 作，进一步规范公司的市值管理行为，切实维护公司、投资者及其他利益相关 者的合法权益，公司积极响应《上市公司监管指引第 10 号——市值管理》中 关于鼓励上市公司建立市值管理制度的号召，根据《中华人民共和国公司法》 《中华人民共和国证券法》《深圳证券交易所股票上市规则》《深圳证券交易 所上市公司自律监管指引第 1 号——主板上市公司规范运作》及其他有关法律 法规，制订本制度。 第二条 本制度所称市值管理，是指公司以提高公司质量为基础，为提升 公司投资价值和股东回报能力而实施的战略管理行为。 第三条 公司牢固树立回报股东意识，采取积极措施保护投资者尤其是中 小投资者利益，规范运作、稳健经营，以新质生产力的培育和运用，推动经营 水平和发展质量提升，并在此基础上做好投资者关系管理，增强信息披露质量 和透明度，必要时积极采取措施提振投资者信心，推动公司投资价值合理反映 公司质量。 第二章 市值管理的目的与基本原则 第四条 市值管理主要目的是通过充分、合规的信息披露，增强公司透明 度，引导公司的市场价值与内 ...